The peroxisome proliferator-activated receptor-γ2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: The Bogalusa Heart Study

Diabetes

Volumn 52, Issue 5, 2003, Pages 1265-1269

  Li, Shengxu ^a   Chen, Wei ^a   Srinivasan, Sathanur R ^a   Boerwinkle, Eric ^b   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; DIABETOGENESIS; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGING; ALANINE; AMINO ACID SUBSTITUTION; BLOOD GLUCOSE; CHILD; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0037407432     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1265     Document Type: Article

References (37)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. Auwerx J: PPAR gamma, the ultimate thrifty gene. Diabetologia 42:1033-1049, 1999
4. Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
5. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer SD: Isolation of the human peroxisome proliferator activated receptor ganuna cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4:281-299, 1995
6. Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE, Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224:431-437, 1996
7. Beamer BA, Negri C, Yen CJ, Gavrilova O, Rumberger JM, Durcan MJ, Yarnall DP, Hawkins AL, Griffin CA, Burns DK, Roth J, Reitman M, Shuldiner AR: Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene. Biochem Biophys Res Commun 233:756-759, 1997
8. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327, 1997
9. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR ganuna 2 missense mutation. Biochem Biophys Res Commun 241:270-274, 1997
10. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C, Kadowaki T: The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216, 2000
11. Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O: Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptorgamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 44:1170-1176, 2001
12. Jacob S, Stumvoll M, Becker R, Koch M, Nielsen M, Loblein K, Maerker E, Volk A, Renn W, Balletshofer B, Machicao F, Rett K, Haring HU: The PPAR gamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm Metab Res 32:413-416, 2000
13. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPAR gamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
14. Chuang LM, Hsiung CA, Chen YD, Ho LT, Sheu WH, Pei D, Nakatsuka CH, Cox D, Pratt RE, Lei HH, Tai TY: Sibling-based association study of the PPAR gamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study: Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. J Mol Med 79:656-664, 2001
15. Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S, Haring H: Pro12Ala polymorphism in the peroxisome proliferator-activated receptorgamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50:876-881, 2001
16. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuonulehto J: The peroxisome proliferator-activated receptorgamma2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes 50:886-890, 2001
17. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, Inoue I, Seino Y, Yasuda K, Hanafusa T, Yamagata K, Awata T, Kadowaki T, Hara K, Yamada N, Gotoda T, Iwasaki N, Iwamoto Y, Sanke T, Nanjo K, Oka Y, Matsutani A, Maeda E, Kasuga M: The Pro12 → Ala substitution in PPAR-gamma: is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891-894, 2001
18. Ringel J, Engeli S, Distler A, Sharma AM: Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Biochem Biophys Res Commun 254:450-453, 1999
19. Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer BA, Shuldiner AR, Akanuma Y, Yazaki Y, Kadowaki T: Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 251:195-198, 1998
20. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V: Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 48:1466-1468, 1999
21. Oh EY, Min KM, Chung JH, Min YK, Lee MS, Kim KW, Lee MK: Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801-1804, 2000
22. Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring HU: The PPAR ganuna2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 42:758-762, 1999
23. Zimmet PZ, Collins VR, Dowse GK, Knight LT: Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:534-541, 1992
24. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Bennett PH, Knowler WC: Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia 37:617-623, 1994
25. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
26. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS: Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol 133:884-899, 1991
27. Bao W, Srinivasan SR, Wattigney WA, Berenson GS: Persistence of multiple cardiovascular risk clustering related to Syndrome X from childhood to young adulthood: the Bogalusa Heart Study. Arch Intern Med 154:1842-1847, 1994
28. Porkka KV, Viikari JS, Taimela S, Dahl M, Akerblom HK: Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up: the Cardiovascular Risk in Young Finns study. Am J Epidemiol 140:1096-1110, 1994
29. Lauer RM, Clarke WR: Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine Study. JAMA 264:3034-3038, 1990
30. Hanis CL, Sing CF, Clarke WR, Schrott HG: Multivariate models for human genetic analysis: aggregation, coaggregation, and tracking of systolic blood pressure and weight. Am J Hum Genet 35:1196-1210, 1983
31. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G: Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study. Atherosclerosis 143:435-443, 1999
32. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS: Influence of lipoprotein lipase Serine447Stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study. Atherosclerosis 159:367-373, 2001
33. The Bogalusa Heart Study 20th Anniversary Symposium. Am J Med Sci 310 (Suppl. 1):S1-S138, 1995
34. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV: Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York, Oxford University Press, 1980
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
36. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ: Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: the Minneapolis Children's Blood Pressure Study. Circulation 99:1471-1476, 1999
37. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 265:2037-2048, 1994